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IMMUNOBIOLOGY
Homeostatic cytokines orchestrate the segregation of CD4 and CD8 memory
T-cell reservoirs in mice
Lili Yang,1 Yang Yu,1 Manorama Kalwani,1 Tai-Wei Joy Tseng,1 and David Baltimore1
1Division of Biology, California Institute of Technology, Pasadena, CA
Memory T cells (TMs) have been detected
in many tissues but their quantitative
distribution remains largely undefined.
We show that in mice there is a remark-
ably biased accumulation of long-term
CD4 TMs into mucosal sites (mainly gut,
especially Peyer patches), and CD8 TMs
into lymph nodes and spleen (in particu-
lar, peripheral lymph nodes [PLNs]). This
distinction correlates with their differenti-
ated expression of PLN- and gut-homing
markers. CD8 and CD4 TMs selectively
require the expression of PLN-homing
marker CCR7 or gut-homing marker 47
for maintenance. PLNs and gut supply
CD8 and CD4 TMs with their individually
favored homeostatic cytokine, IL-15, or
IL-7. Cytokine stimulation in turn regu-
lates the different gut-homing marker ex-
pression on CD4 and CD8 TMs. IL-15 plays
a major role in vivo regulating CD8 TMs
homing to PLNs. Thus, the reservoir
segregation of CD4 and CD8 TMs meets
their individual needs for homeostatic
cytokines and is under feedback control
of cytokine stimulation. (Blood. 2011;
118(11):3039-3050)
Introduction
A prominent feature of T-cell immunity is the formation of memory
T cells (TMs) after exposure to infectious agents, leading to more
effective immune protection on re-encountering the same stimu-
lus.1 CD4 and CD8 T cells carry out distinct immunologic
functions: while CD8 T cells are specialized for cytotoxicity,2 CD4
T cells play a more comprehensive role through helping CD8
T cells and B cells to respond and generate memory,3,4 and through
constituting specialized compartments like TH17 cells and
T regulatory cells.5,6 CD4 and CD8 T cells show considerable
differences in their memory generation and maintenance.7-10 For
example, CD8 TM differentiation appears to be efficient and
follows a linear differentiation pathway, whereas CD4 TM differen-
tiation is more complex and requires a prolonged period of
stimulation.8 In the absence of antigen, TMs are maintained mainly
through interactions with homeostatic cytokines, with CD8 TMs
particularly depending on IL-15 while CD4 TMs primarily depend
on IL-7.10
Homeostatic cytokines are mainly produced by nonhematopoi-
etic tissue cells and considered to be supplied largely in a
tissue-restricted manner in limited amount.11,12 TMs need to home
to special “niches” to efficiently access and compete for these
survival factors.13,14 The search for such “niches” and the associ-
ated reservoir distribution for TMs has been severely hampered by
the technical difficulty of systemically tracking and quantifying
TMs.9,11 Recently, bone marrow (BM) has been proposed as an
important reservoir for both CD8 and CD4 TMs, which is consid-
ered to contain niches defined by IL-7–expressing stromal cells.15-17
However, the systemic distribution of TM reservoirs, especially the
direct comparison between CD4 and CD8 TM reservoirs, remains
largely unexamined.
In the past decade, the increasing application of molecular
imaging techniques for studying the immune system has yielded
valuable insights into the dynamics of the immune cells.18-20
Among them, BLI is especially suitable for studying T-cell
trafficking in small animal models, because of its capacity for
noninvasive measurement of T-cell dynamics in vivo, its excellent
signal-to-noise ratios, and its user-friendly and relatively inexpen-
sive instrumentation.20
Aided by the BLI technique, we have systemically analyzed and
compared the reservoir distribution of long-term CD4 and CD8
TMs in mice. We find that although both TMs are found in multiple
tissues, their preferences for individual tissues are quite different:
CD8 TMs accumulate mainly in lymph nodes and spleen, particu-
larly PLNs whereas CD4 TMs accumulate preferentially in mucosal
sites, mainly gut and especially Peyer patches (PPs). This polarized
accumulation correlates with their differing expression of PLN-
and gut-homing markers. Deficiency of a gut-homing marker 47
or a PLN-homing marker CCR7 selectively impairs the formation
and maintenance of CD4 or CD8 TMs. PLNs produce high level of
IL-15, making them particularly fit as a home for CD8 TMs while
gut expresses IL-7, making it appropriate for CD4 TMs. In addition,
IL-7 and IL-15 stimulation sustains the differentiated expression of
homing markers on the CD4 and CD8 TMs, providing an apparent
feedback control to stabilize their reservoir segregation.
Methods
Mice and materials, antibodies and flow cytometry, tissue lymphocytes
isolation, DC-directed lentivirus infection, CD4 effector T cells (TEs)
differentiation in vitro, CD4 memory T cells (TMs) functional analysis, and
IL-7 and IL-15 mRNA tissue expression are provided in supplemental
Methods (available on the Blood Web site; see the Supplemental Materials
link at the top of the online article). All mouse experiments were approved
by the California Institute of Technology Institutional Animal Care and Use
Committee.
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MFG retrovirus
The MFG construct was generated by inserting into the MSCV retroviral
vector21 the Fluc and EGFP genes linked by a P2A sequence.22 Retroviruses
were made using HEK293.T cells as previously described.21
Effector T cell (TE) culture, transduction, MACS sorting and
adoptive transfer
To generate polyclonal TEs, SP, and LN cells harvested from B6 female
mice were cultured in T-cell culture media containing 0.5 g/mL anti–
mouse CD3 and 0.5 g/mL anti–mouse CD28 (Biolegend) for 3 days. To
generate antigen-specific TEs, SP, and LN cells harvested from OT1 or OT2
Tg mice were cultured in T-cell culture medium containing either
0.1 g/mL OVAp257-269 or 1 g/mL OVAp323-339 for 3 days. To generate
MFG-labeled TEs, on day 1 and day 2 of the culture, T cells were
spin-infected with retroviral supernatant supplemented with 10 g/mL
polybrene for 90 minutes at 770g at 30°C. CD4 and CD8 TEs were purified
using MACS sorting through positive-selection (Miltenyi Biotec). For
adoptive transfer, purified CD4 or/and CD8 TEs (2-20 106/recipient),
supplemented with freshly isolated BM cells (5-10 106/recipient), were
injected intravenously into recipient mice that had received 1000 rads of
total body irradiation. Postadoptive transfer, the recipient mice were
maintained on the mixed antibiotic sulfmethoxazole and trimethoprim oral
suspension (Hi-Tech Pharmacal) for 4 weeks.
Bioluminescence imaging
Bioluminescence imaging (BLI) was performed using an IVIS200 imaging
system (Xenogen/Caliper LifeSciences). Live animal imaging was acquired
5 minutes after intraperitoneal injection of D-Luciferin (1 mg/mouse,
Xenogen/Caliper Lifesciences). To image tissues, mice that received
intraperitoneal injection of D-Luciferin (3 mg/mouse) were dissected
5 minutes after injection; the individual tissues were imaged within the
following 15 minutes. Imaging results were analyzed using a Living
Imaging 2.50 software.
In vitro and in vivo cytokine stimulation for TMs
For in vitro stimulation, CD4 or CD8 TMs were cultured in T-cell culture
media supplemented with 100 ng/mL of either IL-7 or IL-15 for 3 days. For
in vivo stimulation, each mouse received a single intraperitoneal injection
of 10 g of either IL-7 or IL-15 once daily for 5 sequential days.
Statistical analyses
Student t test was used for paired comparisons. Data are presented as
mean  SEM, unless otherwise indicated.
Results
Visualizing the segregation of CD4 and CD8 TM reservoirs in
mice
To track TMs in mice, we constructed a dual-reporter retroviral
vector, MFG, coexpressing firefly luciferase (FLuc) and enhanced
green fluorescence protein (EGFP; Figure 1A). OVA-specific CD4
(OT2) and CD8 (OT1) effector T cells (TEs) were generated in
vitro, transduced with MFG, separately transferred into albino
B6 recipient mice and tracked in vivo using BLI (supplemental
Figure 1A). This approach allowed us to visualize the formation of
TMs in an antigen-free host developing from a relatively homoge-
neous and synchronized population of TEs.21,23-24 Estimation of the
pool size of the transferred cells by measuring the total body
luminescence (TBL) of a recipient mouse divided TM formation
into 3 phases: expansion (weeks 1-3), contraction (week 4) and
stabilization ( 1 month; Figure 1B,C), which closely resembles
the TM formation kinetics during an acute infection.25 FACS
analysis confirmed that both OT2 and OT1 T cells at the stabiliza-
tion phase have acquired the typical TM phenotype:
CD25CD69CD62Lhi/loCD44hi (supplemental Figure 1B).
In the early expansion phase (weeks 1 and 2), OT2 and OT1
T cells exhibited similar disseminated distribution patterns: they
were initially detected in the lung (as early as 14 hours after
transfer), probably because lung is the first organ they enter on
exiting the heart (Figure 1B and supplemental Figure 2A), followed
by movement to many other lymphoid and nonlymphoid tissues,
including lymph nodes (LNs), spleen (SP), bone marrow (BM),
liver, pancreas (Pan), thymus (Thy), genital tract (GT) and gut
(supplemental Figure 2B). Differences in distribution patterns
appeared in the later expansion phase (week 3), became evident
during the contraction phase (week 4), and were maintained
throughout the stabilization phase ( 1 month), for as long as the
TMs were detectable (up to 1 year in our experiments; Figure
1B-D). Comparison of individual tissues for OT2 and OT1 TM
accumulation showed that they could be classified into 4 groups
(Figure 1D): (1) OT1 TM-favored reservoirs, which included
peripheral LNs (PLNs), mesenteric LNs (MLNs) and SP, showing
 3-5 fold higher total luminescence (TL) for OT1 TMs than
OT2 TMs; (2) common reservoirs, which included BM, lung, and
liver, showing similar TL levels; (3) OT2 TM-favored reservoirs,
which included mucosal sites like gut and genital tract, showing
 5- to 10-fold higher TL signals for OT2 TMs than OT1 TMs; and
(4) un-favored reservoirs, which included all other tissues.
Overall, the OT1 TMs preferentially accumulated in LNs and SP,
particularly PLNs; whereas OT2 TMs preferred to accumulate in
mucosal sites including genital tract and gut, with gut containing
the most OT2 TMs because of its large size. Imaging of the isolated
gut showed that OT2 TMs distributed through the entire gut tract
from stomach to colon, with PPs identified as “hot spots” contain-
ing highly concentrated OT2 TMs (Figure 1E). Quantification of the
TL in gut sub-regions showed that the small intestine, appendix/
cecum, stomach and colon contained 80%, 10%, 5%, and 5% of
the gut OT2 TMs, respectively (Figure 1E).
Because OT2 and OT1 T cells were specific for a model Ag,
OVA, we asked whether this distinct TM homing pattern was
general or unique to this Ag. When MFG-labeled polyclonal CD4
and CD8 TEs were transferred into albino B6 recipients (supplemen-
tal Figures 1C-D), the resulting CD4 and CD8 TMs showed a
similar segregated accumulation (Figure 1F), suggesting that it was
a general feature of long-term TMs independent of their Ag
specificity. FACS analysis also confirmed that in the stabilization
phase, both the MFG-labeled polyclonal CD4 and CD8 T cells
displayed typical TM phenotype CD25CD69CD44hiCD62Lhi/lo
(supplemental Figure 1D).
Various types of CD4 and CD8 TMs show a similar polarized
tissue distribution
Because BLI is only a semi-quantitative method, we further
analyzed the tissue distribution of polyclonal CD4 and CD8 TMs
generated through adoptive transfer of effector T cells using flow
cytometry. When equal numbers of B6 CD4 and CD8 TEs were
cotransferred into Thy1.1 congenic recipient mice, the resulting
CD4 and CD8 TMs generated in the recipients exhibited different
CD4TM/CD8TM ratios in individual tissues. In agreement with the
BLI study, scoring individual tissues by calculating the log2 of their
CD4TM/CD8TM ratios classified them into “CD8 TM-favored
reservoirs” that had negative scores (including PLN, peripheral
blood, MLN and SP), “common reservoirs” that had scores close to
zero (including BM and lung), and “CD4 TM-favored reservoirs”
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Figure 1. Visualizing the segregation of CD4 and CD8 TM reservoirs in mice. (A) Schematic representation of dual-reporter retrovector MFG. LTR indicates long-term
repeats; Fluc, firefly luciferase; P2A, porcine teschovirus 2A sequence; EGFP, enhanced green fluorescence protein; and WRE, woodchuck responsive element.
(B,C) Visualization of the CD4 and CD8 TM formation in albino B6 mice postadoptive transfer of 1  106 MFG-labeled OT2 (CD4) or OT1 (CD8) effector T cells (TEs) using BLI.
Representative BLI images (B) and the measurements of total body luminescence (TBL, mean  SEM; C) are shown (n 	 4). Shaded area marks contraction phase (C).
(D,E) Visualization of the CD4 and CD8 TMs in individual tissues using excised tissue BLI. (D) Tissues were collected from albino B6 recipient mice 2 months after transfer of
10  106 MFG-labeled OT2 (CD4) or OT1 (CD8) TEs. PLN indicates peripheral lymph node; MLN, mesenteric LN; SP, spleen; BM, bone marrow; Thy, thymus; GT, genital tract;
and Savi, salivary gland. (E) Detailed analysis of CD4 TM homing to gut. BLI images of the gut tract (top, the “hot spots” are numbered), identification of the “hot spots” as Peyer
patches (PPs; middle), and the measurements of luminescence in gut sub-regions (bottom) are shown. Data are representative of 3 independent experiments. (F) Visualization
of the antigen-specific or polyclonal CD4 and CD8 TMs formed in albino B6 recipient mice each receiving 1  106 either MFG-labeled OT2 or OT1 TEs, or MFG-labeled B6 CD4
or CD8 TEs using BLI. Representative BLI images collected 1 month after transfer are shown (n 	 4). Schematic showing the individual tissue localization in mice is provided
for reference. CLNs indicate cervical LNs; A/BLNs, axillary/brachial LNs; and IgLN, inguinal LNs. PLNs refer to the combination of CLNs, A/BLNs, and IgLNs.
SEGREGATION OF CD4/8 MEMORY T-CELL RESERVOIRS 3041BLOOD, 15 SEPTEMBER 2011  VOLUME 118, NUMBER 11  For personal use only.2011. 
 at CALIFORNIA INST TECH/MILLIKAN LIBRARY on September 30,bloodjournal.hematologylibrary.orgFrom 
that had positive scores (including the lamina propria [LP] and
PP in gut; Figure 2A top and supplemental Figure 3A). In particular,
PLN and PP had the lowest (1.8) and highest ( 3) scores,
confirming that they were the most polarized reservoirs for CD8
and CD4 TMs, respectively. Interestingly, a low score (1.5) for
peripheral blood was obtained, showing more CD8 TMs in
circulation.
We further used this scoring method to study the tissue
distribution of the CD4 and CD8 TMs developed endogenously in
unperturbed mice using flow cytometry. Both memory-phenotype
(MP) TMs spontaneously generated in aged mice10 (Figure 2A
middle and supplemental Figure 3B) and the antigen-specific TMs
induced in vivo through infecting OT1 and OT2 transgenic mice
with a DC-directed lentivirus that expresses OVA antigen26 (Figure
2A bottom and supplemental Figure 3C) showed a similarly
polarized tissue distribution of CD4 and CD8 TMs. Importantly, this
distinct reservoir distribution is unique for memory CD4 and CD8
T cells, because a similar analysis of naive CD4 and CD8 T cells
(TNs) revealed a much different distribution pattern (supplemental
Figure 3E), suggesting that a unique homing propensity is acquired
during memory formation.
Because TMs are heterogeneous in regard to their phenotype and
functionality,7,9,27 we also studied the tissue distribution of TM
subtypes. Based on their expression of CD62L and CCR7, both
CD4 and CD8 TMs can be divided into TCMs and TEMs.28,29 Despite
the classic definition that TCMs home to LNs while TEMs home to
peripheral tissues, analysis of MP CD4 and CD8 TEMs (CD62L)
and TCMs (CD62L
) in aged mice revealed the presence of both
TEMs and TCMs in all the tissues that we studied, although at various
ratios (Figure 2B and supplemental Figure 3F). Of note, in addition
to the overall gut-tropic accumulation for CD4 TMs and LN/SP-
tropic accumulation of CD8 TMs, there are slightly differed tissue
Figure 2. Various types of CD4 and CD8 TMs show a similar polarized tissue distribution. (A) Tissue distribution of CD4 and CD8 TMs of various originalities. Top: CD4 and
CD8 TMs (gated as Thy1.2
CD4
 and Thy1.2
CD8
, respectively) generated in the Thy1.1 congenic mice 2 months after transfer of a mix of equal number (10  106) of B6
CD4 and CD8 TEs; middle: memory-phenotype (MP) CD4 TMs (gated as CD4
CD25CD44hi, CD25 staining was included to gate off Tregs) and CD8 TMs (gated as
CD8
TCR
CD44hi, TCR staining was included to gate off the CD8
 non T cells present in some tissues) spontaneously generated in 1-year-old B6 mice (similar results
were observed for B6 mice aged from 3 months to 1 year); and bottom: OVA antigen-specific OT2 TMs (gated as CD4
CD25TCRV5
CD44hi, CD25 staining was included to
gate off Tregs) and OT1 TMs (gated as CD8
TCRV5
CD44hi) generated in OT2 or OT1 transgenic mice 2 months after infection with 1  108 TU DC-directed lentivirus
expressing OVA antigen. Data are presented as mean  SEM (n 	 4). (B) Tissue distribution of CD4 and CD8 TCMs and TEMs. Various tissues were harvested from 1-year-old
B6 mice and analyzed for the presence of MP CD4 and CD8 TCMs and TEMs (gated as CD4
CD25CD44hiCD62L
, CD4
CD25CD44hiCD62L, CD8
TCR
CD44hiCD62L
,
or CD8
 TCR
CD44hiCD62L, respectively) using flow cytometry. Histogram plots (top) and quantification of TMs (bottom) are shown. Data are presented as mean  SEM
(n	 4). TCMs indicates central memory T cells; and TEMs, effector memory T cells. (C) Visualization of the CD4 TMs formed in abino B6 mice each receiving 1 106 MFG-labeled
CD4TEs that had been differentiated in vitro intoTH0,TH1,TH2, orTH17 cells using BLI. Representative BLI images collected 2 months after adoptive transfer are shown (n	 4). Schematic
showing the individual tissue localization in mice is provided for reference. (D) Functional analysis of MP CD4 TMs residing in PPs of 1-year-old B6 mice. PP cells (pool of 4 mice) were
stimulated with PMA
 Ionomycin in vitro for 6 hours and analyzed for the cytokine production of CD4 TMs (gated as CD4
CD44
) using flow cytometry. Contour plots representative of
3 independent experiments are shown.
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preferences for individual subsets: PPs for CD4 TCMs, LP for CD4
TEMs, PLNs for CD8 TCMs, and SP for CD8 TEMs. CD4 TMs can
also be divided into various subtypes based on their differentiated
functions.9 Differentiating CD4 TEs in vitro into TH0, TH1, TH2, and
TH17 cells followed by adoptively transferring them into recipients
resulted in CD4 TMs that all predominantly accumulated in gut
(Figure 2C), implying that gut might be the common dominant
reservoir for CD4 TMs of various functions.24 This notion is further
supported by the observation that in aged mice, the MP CD4 TMs
harvested from PPs contained subsets that exhibited cytokine
production profiles featured for TH1 (IFN-
IL-4), TH2 (IFN-IL-
4
), and TH17 (IFN-IL-17A
; Figure 2D).
CD4 and CD8 TMs differ on their expression of PLN- and
gut-homing markers
The observation of the extremely polarized gut-tropic versus
PLN-tropic accumulation of CD4 and CD8 TMs raised 2 interesting
questions: how do the TMs achieve this distinct distribution and
what might be the rationale for them to accumulate in these
2 separate tissues? To address the first question, we examined the
expression of several tissue-specific homing markers on CD4 and
CD8 TMs, which have been well documented to control TM traffic
to specific tissues.7,30-32 We were particularly interested in the best
characterized PLN-homing markers CCR7 and CD62L,33,34 and the
gut-homing markers CCR9 and 47.35,36 Examination of the MP
TMs in the spleen of aged mice revealed that both TMs expressed
similar levels of CCR7 and CD62L, but CD4 TMs expressed much
more homogenous and higher levels of CCR9 and 47 than CD8
TMs (Figure 3A). The major difference of 47 expression stems
from the expression of 7 (Figure 3A), its more “gut-specific”
component.36 This PLN- and gut-homing marker expression corre-
lates with their gut-tropic and PLN-tropic accumulation, and was
unique for CD4 and CD8 TMs, because it was not observed for TNs
and TEs (Figure 3A). Further studies of antigen-specific or poly-
clonal TMs generated through adoptive transfer of in vitro differen-
tiated TEs or Ag-specific TMs generated through DC-directed
lentivirus infection all confirmed a PLN- and gut-homing marker
expression pattern similar to MP TMs (supplemental Figure 4A).
In addition, we also analyzed the MP TMs for their expression of
other homing markers that have been indicated to play a role in TM
trafficking, including CCR4, CCR5, CCR6, CCR10, CXCR3, and
CXCR4.30 Different expressions of several markers were observed,
indicating their possible roles in regulating the TM reservoir
distribution as well (supplemental Figure 4B).
We then tracked the homing marker expression on CD4 and
CD8 T cells during their transition from TEs to TMs in recipient
mice postadoptive transfer. Both CD4 and CD8 T cells initially
expressed all the LN-homing and gut-homing markers in the
expansion phase (weeks 1-3; Figure 3C), correlating well with their
similar and ubiquitous presence in various tissues at this stage
(Figure 3B and supplemental Figure 4C). During the contraction
phase (week 4), the critical “turning point” for memory formation,
the CD4 T cells continued up-regulating their expression of both
LN and gut-homing markers while the CD8 T cells started
down-regulating their gut-homing markers (Figure 3C). This
change correlated with a sharp increase of CD8 T cells in PLN, in
concert with the continuous accumulation of CD4 T cells in the gut,
eventually leading to the highly polarized tissue distribution of
CD4 and CD8 T cells as they finished the transition into TMs and
entered the stabilization phase (Figure 3B and supplemental Figure
4C). Therefore, despite their similar expression of PLN-homing
markers, the biased tissue accumulation of CD4 and CD8 TMs
seems to correlate with their differentiated expression of gut
homing markers, which is gradually acquired as they transit from
effector to memory T cells.
CD4 and CD8 TMs selectively require the expression of gut- or
PLN-homing marker for their formation and maintenance
We then sought to determine whether the expression of appropriate
gut- or PLN-homing markers is required for the formation and
maintenance of CD4 and CD8 TMs. Analysis of mice genetically
ablated for a major PLN-homing marker CCR733 revealed that
compared with the age-matched wild-type (WT) mice, they had a
markedly reduced MP CD8 TM population (especially in the
PLNs), but a relatively normal CD4 TM population, shown in both
the CD4TM/CD8TM ratio plot (Figure 4A) and the absolute TM
counts (Figure 4B). On the contrary, mice deficient for a major
gut-homing marker 7 (which results in a deficiency of 47)37
had the opposite phenotype of reduced CD4 but relatively normal
CD8 TMs (Figure 4A-B). Because both CCR7KO and 7KO mice
have other deficiencies in the immune system that may affect their
generation of MP TMs in vivo,33,37 we extracted T cells from these
mice, generated MFG-labeled CD4 and CD8 TEs in vitro, and then
adoptively transferred them into WT recipients. This experimental
design allowed us to confine the CCR7 or 7 deficiency to the
differentiated TEs. Quantification of the TMs formed in the recipient
mice confirmed the previous findings: CCR7 or 7 deficiency
selectively impaired the formation of CD8 or CD4 TMs, respec-
tively, but had little effect on the other (Figure 4C). Notably, the
surviving CCR7KO CD8 TMs mainly resided in gut but not PLNs,
indicating an indispensable role of CCR7 for mediating PLN-tropic
accumulation of CD8 TMs. In contrast, the surviving 7KO CD4
TMs still mostly remained in gut, suggesting that gut-tropic
accumulation of CD4 TMs was not solely dependent on 47
(Figure 4C). Thus, our data imply that CD4 and CD8 TMs
selectively require the expression of gut- or PLN-homing markers,
in particular 47 and CCR7, for their formation and maintenance.
CD4 and CD8 TMs accumulate in tissues that supply them with
their favored homeostatic cytokines
Next, we examined the physiologic relevance of the separate CD4
and CD8 TMs accumulation in gut and PLNs. Considering the
notable difference between CD4 and CD8 TMs of their dependence
on the homeostatic cytokines IL-7 and IL-15,10 we hypothesized
that the distinct tissue distribution of CD4 and CD8 TMs might meet
their individual needs. CD4 and CD8 TMs expressed similar level
of IL-7 receptor (composed of c and IL-7R chains), while CD8
TMs expressed much higher and more homogenous level of IL-15
receptor (evident by a modestly higher level of IL-15R and a
significantly higher level of IL-2/15R [CD122]; Figure 5A). This
distinction was TM-specific because the differences between CD4
and CD8 TNs and TEs were much smaller (supplemental Figure
5A). Tracking IL-2/15R expression on CD4 and CD8 T cells
during their effector to memory transition showed CD8 T cells
maintaining a constant high expression of IL-2/15R while CD4
T cells gradually down-regulated its expression (supplemental
Figure 5B). Stimulating the purified TMs in vitro with either IL-7 or
IL-15 showed that CD8 TMs generally had a proliferation advan-
tage over CD4 TMs, especially when IL-15 was present (Figure
5B). When IL-7 or IL-15 was injected into mice harboring
MFG-labeled CD4 or CD8 TMs, we found that IL-7 induced a
 2.7-fold expansion of CD8 TMs and a  2-fold expansion of
CD4 TMs, whereas IL-15 induced a striking 20-fold expansion of
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CD8 TMs and only a  2-fold expansion of CD4 TMs (Figure
5C-D). Examination of the tissue-specific expression of IL-7 and
IL-15 revealed a relatively homogenous expression of IL-7 in
various tissues with some preference for gut, while IL-15 was
expressed at notably higher level in PLN (Figure 5E). This
distribution makes PLN a particularly attractive reservoir site for
the IL-15–dependent CD8 TMs. Therefore, our results supported a
“homing to fitness” hypothesis: IL-15–dependent CD8 TMs tend to
accumulate in PLNs, the site particularly rich in IL-15 whereas the
IL-7–dependent CD4 TMs tend to accumulate in the gut where they
are provided with IL-7 and do not need to compete with CD8 TMs
for cytokines.
Homeostatic cytokines regulate the differentiated expression
of gut-homing markers on CD4 and CD8 TMs in vitro
In addition to their role in maintaining TM homeostasis, we were
interested to explore whether homeostatic cytokines might also
regulate TM homing molecule expression. To this end, we purified
the MP CD4 and CD8 TMs from B6 mice and cultured them in vitro
in the presence or absence of IL-7 or IL-15. Without cytokines in
the culture, the difference in gut-homing marker expression was
almost extinguished (Figure 6A), implying that the differentiation
was not fixed for TMs but was rather actively acquired through their
constant interaction with external signals, such as homeostatic
Figure 3. CD4 and CD8 TMs differ on their expression of gut-homing markers. (A) Homing marker expression on naive (TN), effector (TE), and memory (TM) CD4 and CD8
T cells analyzed by flow cytometry. CD4 and CD8 TNs (gated as CD4
CD25CD44lo and CD8
 CD44lo, respectively) and TMs (gated as CD4
CD25CD44hi and CD8
CD44hi,
respectively) were naive or memory T cells detected in the spleen of 1-year-old B6 mice. TEs were generated by stimulating B6 spleen T cells in vitro with anti-CD3 and
anti-CD28 for 3 days. Representative histogram plots (top) and measurements of mean fluorescence intensity (MFI; mean  SEM; bottom) are shown (n 	 8).
(B,C) Time-course tracking of CD4 and CD8 T cells (gated as Thy1.2
CD4
 and Thy1.2
CD8
, respectively) for their tissue homing preference (B) and homing marker
expression (C) during their transition from TEs to TMs in Thy1.1 congenic mice receiving adoptive transfer of a mix of equal number (10  106) of B6 CD4 and CD8 TEs. (B) Data
are presented as mean  SEM. (C) Representative homing marker expression on spleen T cells detected by flow cytometry, shown as mean fluorescence intensity (MFI;
mean  SEM). N 	 4. Shaded area marks contraction phase.
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cytokines. Indeed, their differential marker expression was partly
restored when IL-7 was added to the culture medium and, more
strikingly, was almost restored to the in vivo level when IL-15 was
added (Figure 6A). This regaining of the differentiation worked
through reversely up-regulating or down-regulating gut homing
markers on CD4 and CD8 TMs (including both CCR9 and 47),
similarly to what was observed during the TE to TM transition
(Figure 3C). This regulation was specific for gut homing markers
because the PLN-homing marker CD62L was up-regulated on both
CD4 and CD8 TMs in response to either IL-7 or IL-15 stimulation
(Figure 6A). Notably, we observed that both IL-7 and IL-15
stimulation specifically promoted the CD8 TMs, but not CD4 TMs,
to significantly up-regulate IL-2/15R, thereby providing a positive-
feedback control to maintain the different responsiveness to IL-15
between CD4 and CD8 TMs (Figure 6A). Thus, our results indicate
that in addition to their capacity to maintain TM survival and
proliferation, the homeostatic cytokines, especially IL-15, appears
to also regulate the distinct homing of CD4 and CD8 TMs by
maintaining their differential expression of gut-homing markers.
This regulation seems to stem from an intrinsic difference between
CD4 and CD8 TMs as to their response to homeostatic cytokine
stimulation.
IL-15 plays a major role in regulating CD8 TMs homing to PLNs
in vivo
In light of the in vitro study, we further asked whether homeostatic
cytokines, in particular IL-15, might regulate TM homing in vivo.
First we studied the TM distribution in the IL-15KO mice.
Consistent with a previous report,38 we found that compared with
WT mice, IL-15KO mice have a much reduced number of MP CD8
TMs, but their CD4 TMs were relatively unaffected. Although there
was a general reduction of CD8 TMs in all the tissues that we
analyzed, the most significant reduction occurred in the CD8
TM-favored reservoirs, especially in PLNs, resulting in a much less
dramatically polarized distribution of the CD4 and CD8 TMs.
Supplementing the IL-15KO mice with IL-15 greatly expanded
their CD8 TMs. In addition, there was a corrected preference for
CD8 TM to accumulate in PLNs, shown as a more significant
increase of CD8 TMs in PLNs compared with their increases in the
other tissues, which partially restored the polarized tissue distribu-
tion of CD4 and CD8 TMs (Figures 6B-C and supplemental Figure
6B). These finding correlated with the observation that in IL-15KO
mice, the CD8 TMs expressed high levels of gut-homing markers
CCR9 and 47 similar to CD4 TMs (supplemental Figure 6A).
Figure 4. CD4 and CD8 TMs selectively require the expression of 47 or CCR7 for their formation and maintenance. (A) Tissue accumulation of MP CD4 and CD8 TMs
(gated as CD4
CD25CD44hi and CD8
 TCR
CD44hi, respectively) in 10-month-old CCR7KO or 7KO mice. Data are presented as mean  SEM (n 	 4). (B) Comparison
of CD4 and CD8 TM number in PLN and PP of 10-month-old wild-type (WT), CCR7KO and 7KO mice. Data are presented as mean  SEM (n 	 4). (C) Study of the influence
of CCR7 or 7 deficiency on CD4 and CD8 TM formation using BLI. Either MFG-labeled CD4 TEs (5  106) or CD8 TEs (1  106) of the indicated genotype were adoptively
transferred into albino B6 recipient mice. Representative BLI images and total body luminescence (TBL) measurements of the indicated recipients (mean  SEM, n 	 4)
1 month after transfer are shown.
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Figure 5. CD4 and CD8 TMs home to tissues that supply them with their favored homeostatic cytokines. (A) Cytokine receptor expression on the MP CD4 and CD8 TMs
(gated as CD4
CD25CD44hi and CD8
CD44hi, respectively) in the spleen of 1-year-old B6 mice measured by flow cytometry. Representative histogram plots and mean
fluorescence intensity (MFI) measurements are shown (n  4). (B) Proliferation of CD4 and CD8 TMs in response to cytokine stimulation (100 ng/mL) for 3 days in vitro
measured by cell counts. TMs were purified from 1-year-old B6 mice. Representative data are presented as mean of triplicates  SEM (n 	 4). (C,D) Proliferation of CD4 and
CD8 TMs in response to cytokine stimulation in vivo measured by BLI. MFG-labeled OT2 (CD4) or OT1 (CD8) TEs (1  106) were adoptively transferred into each albino
B6 recipient mouse. Six months later, the recipients harboring the OT2 or OT1 TMs received administration (IP) of either IL-7 or IL-15 daily (10 g) for 5 sequential days.
(C) Time-course tracking of the TBL change of the indicated recipient mice receiving either IL-7 or IL-15. Data are presented as mean  SEM. (D) Representative BLI images
of the indicated mice right before the 1st cytokine administration (day 1) and 1 day after the last cytokine administration (day 6; n 	 3-4). (E) Tissue expression of IL-7 and
IL-15 in 1-year-old B6 mice measured by Taqman Q-PCR. Representative data are presented as mean of triplicates  SEM (n 	 4).
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Figure 6. Homeostatic cytokines regulate the differentiated expression of gut-homing markers on CD4 and CD8 TMs in vitro and in vivo. (A) IL-7 and IL-15 regulation
of homing marker expression on MP CD4 and CD8 TMs in vitro. MP CD4 and CD8 TMs (gated as CD4
CD25CD44hi or CD8
CD44hi, respectively) purified from the spleen of
1-year-old B6 mice (pool of 8 mice) were cultured in triplicates in vitro for 3 days in the presence or absence of 100 ng/mL of IL-7 or IL-15. Their expression of homing markers,
as well as IL-2/15R (CD122), was measured by flow cytometry. Data are shown as histogram plots and measurements of mean fluorescence intensity (MFI, presented as
mean of triplicates  SEM), and are representative of at least 3 independent experiments. Red or blue *P  .05 (CD4 or CD8 TMs cultured with cytokine compared with CD4 or
CD8 TMs cultured without cytokine). (B-C) Quantification of MP CD4 and CD8 TMs (gated as CD4
CD25CD44hi and CD8
TCR
CD44hi, respectively) in 9-month-old
IL-15KO mice with or without supplementation of IL-15 (IP 10g daily for 5 sequential days). (B) Tissue distribution of CD4 and CD8 TMs. (C) The fold changes of CD4 and CD8
TM numbers in response to IL-15 treatment in indicated tissues. Data are shown as mean  SEM (n 	 3). (D) Comparison of CD4 and CD8 TM formation in WT or IL-15KO mice
using BLI. MFG-labeled B6 CD4 or CD8 TEs (1  106) were adoptively transferred into either WT (B6) or IL-15KO recipient mice. Representative BLI images and the
measurements of TBL (shown as mean  SEM) of the indicated recipients collected 1 month after transfer are shown (n 	 3). (E,F) The impact of IL-15 supplement on the
homeostasis and homing of CD4 and CD8 TMs studied using BLI. MFG-labeled WT (B6) CD4 or CD8 TEs (5  106) were transferred into IL-15KO recipient mice. One month
later, the recipients were supplemented with IL-15 (IP 10g daily for 5 sequential days). (E) Time-course tracking of the fold change of TBL of the indicated recipients. Data are
presented as mean  SEM. (F) Representative BLI images of the indicated recipients on day 1 (right before the 1st IL-15 administration), day 6, and day 9. N 	 4. Schematics
showing the individual tissue localization in mice (ventral view and left side view) are provided for reference.
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When IL-15 was supplemented, the difference in gut-homing
marker expression was largely restored between CD4 and CD8
TMs, mainly through down-regulating these markers on CD8 TMs
(supplemental Figure 6A). Meanwhile, the PLN-homing marker
CD62L was up-regulated on CD8 TMs, indicating that the down-
regulation was specific for gut-homing markers (supplemental
Figure 6A). Moreover, the difference of IL-2/15R expression on
CD4 and CD8 TMs was greatly reduced in IL-15KO mice, and was
significantly restored on IL-15 supplementation, suggesting that
IL-15 might provide a major positive feedback control in vivo to
differentiate CD4 and CD8 TMs in their responsiveness to IL-15
(supplemental Figure 6A).
To further study the role of IL-15 as a tissue-restricted factor to
regulate CD8 TM homing to PLN, we adoptively transferred
MFG-labeled WT CD4 and CD8 TEs into either WT or IL-15KO
recipients, and then follow their TM formation in vivo. The results
corroborated the previous findings that mice lacking IL-15 did not
effectively support CD8 TM formation, especially their homing to
PLNs, whereas the maintenance and homing of CD4 TMs was
mostly unaffected (Figure 6D). Supplementation with IL-15 in-
duced a significant expansion of CD8 TMs and promoted their
homing to the PLNs, while limited expansion was seen for the CD4
TMs (Figure 6E-F). Taken together, our results indicate that IL-15
supplied by the tissues plays a major role in the regulation of CD8
TM homing to PLNs in vivo. This conclusion is further supported
by the finding that in WT mice, the MP CD4 and CD8 TMs
harvested from PLNs where IL-15 expression is most abundant
showed a more dramatic distinction of gut homing marker expres-
sion compared with those TMs harvested from SP (supplemental
Figure 6C).
Discussion
Despite the detection of CD4 and CD8 TMs in many tissues,1,32,39 a
dynamic and systemic study of the localization of CD4 and CD8
TMs has been lacking, probably because of the difficulty of
quantifying TMs, in particular CD4 TMs, in tissues outside the
dedicated lymphoid organs. Taking advantage of BLI for its
capacity to visualize the TMs in a live animal and in its excised
organs, and combining it with direct measurements, we have
attempted to provide a global picture of CD4 and CD8 TM
localization. We find a remarkably segregated tissue distribution of
long-term CD4 and CD8 TMs in mice. Therefore in addition to their
differences in functionality, anatomic localization is another impor-
tant distinction between these 2 classes of TMs.
The accumulation of CD8 TMs mainly in the classic lymphoid
organs (LNs and SP) was to be expected because they have long
been recovered from these sites but the extremely specific accumu-
lation of CD4 TMs in mucosal sites, particularly gut, and their
relative paucity in LNs and SP was striking. The finding of gut as a
major site for CD4 TM homing is consistent with a previous study
using whole body immunohistology to study CD4 TM distribution
in mice post protein antigen immunization.39 However, despite the
documentation of CD4 TMs being abundant in mucosal sites in
mice, nonhuman primates and humans,31,40 it has not been so
evident that these sites represent specialized dominant reservoirs
for CD4 TMs. What might be the physiologic rationale for the
immune system to place these 2 types of TMs in almost complemen-
tary positions? Considering the different functions that CD4 and
CD8 TMs serve,8,9 it is conceivable that this distribution pattern
allows them to together cover the major portals for sensing
pathogens that enter the body, potentially providing effective
immuno-surveillance. In fact, this distribution may facilitate their
specific functional activities: localization of CD8 TMs in draining
LNs and SP allows them to react quickly to dendritic cells that
sample the invading pathogens in tissues or in the circulation and
differentiate into effector cytotoxic T cells (CTLs) that can cleanse
infected tissues; localization of CD4 TMs to mucosal sites would
allow them to most efficiently respond to pathogens in these sites
by both defending against them directly and helping the local
B cells to produce antibodies protecting the mucosal surface.
It should be noted that certain pathogens take advantage of this TM
distribution to aid their infection process. One example is SIV/HIV
that primarily targets the CCR5-positive CD4 TMs and uses
mucosal sites as its main entry route.40 Massive infection and
depletion of CD4 TMs in gut precedes the infection of other tissues,
and is the most profound T-cell population abnormality in AIDS.41-43
That gut is the predominant reservoir for CD4 TMs helps to explain
the HIV/SIV tissue tropism, emphasizing the importance of
providing mucosal protection in the design of therapeutic or
vaccination strategies against HIV.
What is the physiologic significance for CD4 and CD8 TMs to
separately accumulate in gut or PLNs? TMs depend on homeostatic
cytokines for long-term survival, with CD8 TMs heavily reliant on
IL-15 while CD4 TMs mainly respond to IL-7.10 Our study of tissue
production of these cytokines revealed a relatively homogenous
expression of IL-7 among the tissues (albeit slightly higher in gut)
but a much higher expression of IL-15 in PLNs. Therefore, it seems
that CD8 TMs do benefit from accumulating in PLNs for easy
access to IL-15. Meanwhile, the CD4 TMs in gut have access to
IL-7 and avoid a direct competition with CD8 TMs for cytokines.
Interestingly, commensal microflora have recently been shown to
promote intestinal epithelia cells to produce IL-7,44 implying that
these microbes may play a role in the maintenance of CD4 TMs and
their accumulation at mucosal sites. This notion is supported by our
observation that in germ-free mice, in contrast to a relative constant
level of memory-phenotype CD8 TMs, there is a significant
reduction of CD4 TMs, especially in the gut (supplemental Figure
7). Importantly, we found that homeostatic cytokine stimulation of
CD4 and CD8 TMs actively regulates their expression of homing
markers, providing a potent feedback control for stabilizing their
distinct homing pattern. In particular, IL-15 appears to play the
dominant role by greatly down-regulating the expression of
gut-homing markers on CD8 TMs. Indeed, depriving or supplement-
ing IL-15 in vivo regulates the capacity of CD8 TMs to home to
PLNs. Notably, the expression of IL-15 receptor, particularly its
 subunit (IL-2/15R or CD122), is quite different between CD4
and CD8 TMs and is also subjected to cytokine feedback control,
strengthening their differentiated needs for IL-15.
In Figure 7, we bring together all of our observations into a
“Memory Compartmentalization Model.” Key to the model is that
the memory development process programs CD4 and CD8 TMs into
different regulatory pathways so that they respond differently to the
hematopoietic cytokines. In the absence of cytokine stimulation,
there is little difference between CD4 and CD8 TMs for their
homing marker expression (CD62LloCCR9hi47hi). The cyto-
kines up-regulate the PLN-homing marker CD62L on both TMs, but
greatly down-regulate the gut-homing markers CCR9 and 47 on
CD8 TMs (CD62LhiCCR9lo47lo) while further up-regulate these
markers on CD4 TMs (CD62LhiCCR9hi47hi). This distinction of
gut-homing marker expression leaves CD8 TMs to accumulate in
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PLNs by default. We postulate that CD4 TMs accumulate in gut
because of their relative free exchange between PLNs and circula-
tion but a more restricted exchange back to circulation once they
enter the gut, as suggested by previous report.45 It is relevant to
point out that expression of certain tissue homing marker on TMs
allow them to access the corresponding tissue and stay in that tissue
for certain time, but by no means making them the permanent
residents of that tissue. Instead, all TMs retain their capacity to
survey the body through blood and lymphoid circulation. In the
PLNs, CD8 TMs find a high level of their favored cytokine IL-15,
while in the gut, CD4 TMs find an environment rich in their favored
cytokine IL-7 which they can access without competing with CD8
TMs. The cytokine stimulation in turn stabilizes the PLN-tropic and
gut-tropic accumulation of CD8 and CD4 TMs through down-
regulating or up-regulating their gut-homing markers, respectively.
In addition, the cytokine stimulation also maintains the different
expression of IL-2/15R on CD4 and CD8 TMs, strengthening their
different reliance on IL-15. We should point out that this model
mainly addresses TMs that heavily depend on IL-7 and IL-15 for
maintenance. It is possible that TMs that are sustained through other
forms of regulation may exhibit other homing patterns. For
instance, it has been reported that TMs generated from a localized
infection in a peripheral tissue, such as skin, gut and lung, tend to
be “imprinted” with the capacity to home back to that particular
tissue.31,32,46 It will be interesting for future study to characterize
the homeostatic regulation of these TMs and their whole-body
reservoir distribution.
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Figure 7. Memory compartmentalization model. This schematic model illustrates the segregation of CD4 and CD8 TM reservoirs in mice, and the possible molecular controls
and physiologic relevance of this phenomenon (for details, see main text).
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